¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycogen degeneration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® glycogen ÇÑ±Û ±Û¸®ÄÚ°Õ, ´ç¿ø
¼³¸í   
  µ¿¹°¿¡¼­ Åº¼öÈ­¹°ÀÇ ÀúÀåÇüÅ·ΠÁַΠ°£¿¡ ´ëºÎºÐÀÌ ÀúÀåµÇ¾î ÀÖ°í ±ÙÀ°¿¡ Á¶±Ý ÀÖ´Ù. Æ÷µµ´çÀ¸·Î ºÐÇØµÇ¾î ÀÌ¿ëµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • deposit glycogen
    ÀúÀå±Û¸®ÄÚ°Õ
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen granule
    ±Û¸®ÄÚ°Õ°ú¸³
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûº´, ´ç¿øÃàÀûº´
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ
  • angiolithic degeneration
    Ç÷°üµ¹º¯¼º, ¸Æ°ü°á¼®º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÇà
  • disciform macular degeneration
    ¿ø¹ÝȲ¹Ýº¯¼º
  • elastotic degeneration
    ź·Â¼¶À¯º¯¼º
  • fatty degeneration
    Áö¹æº¯¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • degeneration
    º¯¼º, ÅðÇà
  • axonal degeneration
    Ãà»èº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • postencephalitic degeneration
    ³ú¿°Èĺ¯¼º
  • vacuolar degeneration
    °øÆ÷º¯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • deposit glycogen
    ÀúÀå±Û¸®ÄÚ°Õ
  • glycogen storage disease
    ´ç¿øÃàÀûº´
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen granule
    ±Û¸®ÄÚ°Õ°ú¸³
  • glycogen vacuole
    ´ç¿ø°øÆ÷
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ
  • actinic degeneration
    ±¤¼±º¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • angiolithic degeneration
    ¸Æ°ü°á¼®º¯¼º, Ç÷°üµ¹º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cobblestone degeneration
    ÀÚ°¥¸ð¾çº¯¼º, Á¶¾àµ¹º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÇà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen degeneration
    ±Û¸®ÄÚ°Õº¯¼º(¡­Ü¨àõ).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø(ÓØê«)
  • Glycogen synthase
    ±Û¸®ÄÚ°ÕÇÕ¼º(ùêà÷)
  • Glycogen-lactic acid system
    ±Û¸®ÄÚ°Õ-¶ôÆ®»ê°è
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen
    ±Û¶óÀÌÄÚÀü, ´ç¿ø.
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø.
  • glycogen
    ´ç¿ø, ±Û¸®ÄÚ¿À°Õ
  • glycogen granule
    ±Û¸®ÄÚ°Õ°ú¸³
  • glycogen granule
    ´ç¿ø°ú¸³
  • glycogen phosphorylase
    ±Û¸®ÄÚ°ÕÆ÷½ºÆ÷¸±¶ó¾ÆÁ¦
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • glycogen synthase
    ´ç¿ø ÇÕ¼ºÈ¿¼Ò
  • granule, glycogen
    ±Û¸®ÄÚ°Õ°ú¸³
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen degeneration
    ±Û¸®ÄÚ°Õº¯¼º(¡­Ü¨àõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • deposit glycogen
    ÀúÀå(îÍíú)±Û¸®ÄÚ°Õ.
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø.
  • glycogen
    ´ç¿ø, ±Û¸®ÄÚ¿À°Õ
  • glycogen
    ±Û¶óÀÌÄÚÀü, ´ç¿ø.
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen granule
    ±Û¸®ÄÚ°Õ°ú¸³
  • glycogen granule
    ´ç¿ø°ú¸³
  • glycogen phosphorylase
    ±Û¸®ÄÚ°ÕÆ÷½ºÆ÷¸±¶ó¾ÆÁ¦
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen synthase
    ´ç¿ø ÇÕ¼ºÈ¿¼Ò
  • granule, glycogen
    ±Û¸®ÄÚ°Õ°ú¸³
  • hepatic glycogen
    °£(ÊÜ)±Û¸®ÄÚ°Õ.
  • kidney,glycogen vacuolation
    ±Û¸®ÄÚ°Õ°øÆ÷È­(¡­Íöøàûù)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glycogen granule
    ´ç¿ø°ú¸³
    [¿¾ ¿ë¾î] ´ç¿ø°ú¸³
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen vacuoles
    ´ç¿ø°øÆ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fatty degeneration
    Áö¹æÅðÇà(ò·Û¸÷Üú¼)
  • glycogen
    ±Û¶óÀÌÄÚÀü
  • glycogen granule
    ±Û¶óÀÌÄÚÀü °ú¸³(Ψأ)
  • glycogen phosphorylase
    ±Û¶óÀÌÄÚÀü Æ÷½ºÆ÷¸±·¹À̽º
  • glycogen storage disease
    ±Û¶óÀÌÄÚÀü ÀúÀå Áúȯ(îÍíúòðü´)
  • glycogen synthase
    ±Û¶óÀÌÄÚÀü ½ÅÅ×À̽º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen storage disease
    ±Û¸®ÄÚ°Õ ÃàÀûÁúȯ
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÈ­
  • fat degeneration
    Áö¹æº¯¼º
  • fatty degeneration
    Áö¹æº¯¼º
  • malignant degeneration
    ¾Ç¼ºÈ­
  • myxomatous degeneration
    Á¡¾×Á¾¼ºº¯¼º
  • retrograde degeneration
    ¿ªÇ༺º¯¼º
  • sclerotic degeneration
    °æÈ­¼ºº¯¼º
  • Wallerian degeneration
    ¿Ð·¯º¯¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
RD radial deviation; radiology department; rate difference; Raynaud disease; reaction of degeneration; ...
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
GFFS glycogen and fat-free solid
GSD genetically significant dose; Gerstmann-Straussler disease; glutathione synthetase deficiency; glyco...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GSK-3 beta I)/glycogen synthase kinase-3 beta
Gly Glycogen
GP Glycogen Phosphorylase
GSD Glycogen Storage Disease
GSDII Glycogen Storage Disease type II
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • labile glycogen
    ºÒ¾ÈÁ¤ ±Û¸®ÄÚ°Õ
  • actinic degeneration
    ±¤¼± º¯¼º
  • amyloid degeneration
    ¾Æ¹Ð·ÎÀÌµå º¯¼º
  • axonal degeneration
    Ãà»è º¯¼º
  • ballooning degeneration
    °øÆ÷ º¯¼º, dz¼± º¯¼º, ±â±¸»ó º¯¼º
    Ç¥ÇÇ ¼¼Æ÷³» ºÎÁ¾À¸·Î ÀÎÇÏ¿© ¼¼Æ÷ÀÇ ½ÉÇÑ ÆØÃ¢À» ÀÏÀ¸Å² °Í.
  • calcareous corneal degeneration
    ¼®È¸ °¢¸· º¯¼º
  • calcific degeneration
    ¼®È¸È­ º¯¼º, ÅðÇ༺ ¼®È¸È­
    Ä¡¼ö½Ç º¸´Ù Ä¡¼ö °ü¿¡¼­ ÈçÇÏ´Ù. ¾àÇÑ µ¿Åë. ±¹¼Ò ´ë»ç Àå¾Ö³ª ¼Õ»ó ¼¼Æ÷ÀÇ ÃÊÀÚÈ­ µîÀÌ ¿øÀÎÀÌ´Ù.
  • cancerous degeneration
    ¾Ï º¯¼º
    ¾ÏÀ¸·Î º¯È¯ÇÏ´Â °Í. ¿¹¸¦ µé¸é ¾ç¼º Á¾¾ç¿¡¼­ ¾ÏÀ¸·Î º¯È¯ÇÏ´Â °Í.
  • cartilage degeneration
    ¿¬°ñ º¯¼º
    ¿¬°ñÀÌ °íµµÀÇ ÇüÀ¸·ÎºÎÅÍ ÀúµµÀÇ ÇüÀ¸·Î º¯È­.
  • cell,hydropic degeneration
    ¼öÆ÷¼º º¯¼º
  • cerebellar degeneration
    ¼Ò³ú º¯¼º
  • cerebromacular degeneration
    ³ú Ȳ¹Ý º¯¼º
  • cobblestone degeneration
    ÀÚ°¥ ¸ð¾ç º¯¼º, Æ÷¼®»ó º¯¼º
  • colloid degeneration
    ÄÝ·ÎÀÌµå º¯¼º
  • corneal degeneration
    °¢¸· º¯¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
brancher glycogen storage disease Type of glycogen storage disease, due to deficiency of amylo-1,4-1,6-transglucosidase (brancher enzyme).
Synonym: brancher deficiency glycogenosis, debrancher deficiency.
(05 Mar 2000)
glycogen <biochemistry> Branched polymer of D glucose (mostly _(1-4) linked, but some _(1-6) at branch points).
Size range very variable, up to 10exp5 glucose units. Major short term storage polymer of animal cells and is particularly abundant in the liver and to a lesser extent in muscle. In the electron microscope glycogen has a characteristic asterisk or star appearance.
(18 Nov 1997)
glycogen debranching enzyme system 1,4-alpha-d-glucan-1,4-alpha-d-glucan 4-alpha-d-glucosyltransferase/dextrin 6 alpha-d-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (ec 2.4.1.25) and amylo-1,6-glucosidase (ec 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-d-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-d-glucan. As a glucosidase it catalyses the endohydrolysis of 1,6-alpha-d-glucoside linkages at points of branching in chains of 1,4-linked alpha-d-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
(12 Dec 1998)
glycogen granule Glycogen occurring in cells as beta granule's which average about 300 A
glycogen phosphorylase <enzyme> Enzyme that catalyses the sequential removal of glycosyl residues from glycogen to yield one glucose-1-phosphate per reaction. Its activity is controlled by phosphorylation (by phosphorylase kinase).
(21 Jun 2000)
glycogen storage disease <hepatology> A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalised storage of glycogen occurs, sometimes with prominent cardiac involvement.
Synonym: glycogenosis
(12 Sep 2002)
glycogen storage disease type I <disease> An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycaemia due to lack of glucose production.
Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
Inheritance: autosomal recessive.
(12 Dec 1998)
glycogen storage disease type II <disease> Glycogenosis due to alpha-1,4-glucosidase (acid maltase) deficiency. It affects muscle, heart, and other organs.
(12 Dec 1998)
glycogen storage disease type III <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system).
The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type IV <disease> An autosomal recessive metabolic disorder due to a deficiency in expression of branching enzyme (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. Clinical features are muscle hypotonia and cirrhosis. Death from liver disease usually occurs before age 2.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type V <disease> Glycogenosis due to muscle phosphorylase deficiency. Characterised by painful cramps following sustained exercise.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type VI <disease> A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. However, studies have not been able to distinguish between phosphorylase deficiency and phosphorylase kinase deficiency in patients with hepatic glycogenosis.
(12 Dec 1998)
glycogen storage disease type VII <disease> An autosomal recessive muscle glycogen storage disease in which there is deficient expression of muscle phosphofructokinase activity, resulting in increased concentrations of glucose-6-phosphate and fructose-6-phosphate and low concentrations of fructose-1,6-diphosphate in muscle tissue.
Glycogen storage in muscle is increased, perhaps due to activation of glycogen synthase by accumulated glucose-6-phosphate. It has been proposed that shunting of glucose-6-phosphate and fructose-6-phosphate into the pentose phosphate pathway may result in increased synthesis of purines and pyrimidines, causing hyperuricaemia and gout.
Erythrocytes from patients may show decreased phosphofructokinase activity and 2,3-diphosphoglycerate deficiency. Exercise intolerance is present and severe congenital muscular dystrophy has been reported.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type VIII <disease> An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.
Inheritance: X-linked recessive
(12 Dec 1998)
glycogen synthase <enzyme> An enzyme of the transferase class that catalyses the reaction of udpglucose and (1,4-alpha-d-glucosyl)n to yield udp and 1,4-alpha-d-glucosyl)n+1. The reaction is highly regulated by allosteric effectors, by phosphorylation reactions, and by insulin.
Chemical name: UDPglucose:glycogen 4-alpha-D-glucosyltransferase
Registry number: EC 2.4.1.11
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen
    ±Û¸®ÄÚ°Õ
  • degeneration
    Åðº¸;Ÿ¶ô;¾ÇÈ­
  • fatty degeneration
    Áö¹æ º¯Áú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á